Lewis H Mervin (Lewis Mervin)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 8

Top Venues

Journal of chemical information and modeling

ACS chemical biology

Journal of cheminformatics

AstraZeneca R&D Cambridge

University of Cambridge (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AstraZeneca R&D Cambridge Aug 01 2019

United Kingdom

Machine Learning and Cheminformatics Expert :: Discovery Sciences

University of Cambridge Aug 01 2018 - Aug 01 2019

United Kingdom

Postdoctoral Research Associate :: Chemistry

AstraZeneca R&D Alderley Park Oct 01 2013

United Kingdom

Industrial CASE Studentship :: Discovery Sciences

Education History

University of Cambridge Oct 01 2014

United Kingdom

PHD :: Chemistry

University of Manchester Sep 25 2009 - Jul 01 2012

United Kingdom

BSC :: Life Sciences

Publications

Lewis H Mervin, Alexey Voronov, Mikhail Kabeshov, Ola Engkvist
QSARtuna: An Automated QSAR Modeling Platform for Molecular Property Prediction in Drug Design. Journal of chemical information and modeling (2024)
Lewis H Mervin, Alexey Voronov, Mikhail Kabeshov, Ola Engkvist
QSARtuna: An Automated QSAR Modeling Platform for Molecular Property Prediction in Drug Design. Journal of chemical information and modeling 64 (14) (2024)
Wouter Heyndrickx, Lewis H Mervin, Tobias Morawietz, Noé Sturm, Lukas Friedrich, Adam Zalewski, Anastasia Pentina, Lina Humbeck, Martijn Oldenhof, Ritsuya Niwayama, Peter Schmidtke, Nikolas Fechner, Jaak Simm, Adam Arany, Nicolas Drizard, Rama Jabal, Arina Afanasyeva, Regis Loeb, Shlok Verma, Simon Harnqvist, Matthew Holmes, Balazs Pejo, Maria Telenczuk, Nicholas Holway, Arne Dieckmann, Nicola Rieke, Friederike Zumsande, Djork-Arné Clevert, Michael Krug, Christopher Luscombe, Darren Green, Peter Ertl, Peter Antal, David Marcus, Nicolas Do Huu, Hideyoshi Fuji, Stephen D Pickett, Gergely Acs, Eric Boniface, Bernd Beck, Yax Sun, Arnaud Gohier, Friedrich Rippmann, Ola Engkvist, Andreas H Göller, Yves Moreau, Mathieu N Galtier, Ansgar Schuffenhauer, Hugo Ceulemans
MELLODDY: Cross-pharma Federated Learning at Unprecedented Scale Unlocks Benefits in QSAR without Compromising Proprietary Information. Journal of chemical information and modeling (2023)
Maria-Anna Trapotsi, Elizabeth Mouchet, Guy Williams, Tiziana Monteverde, Karolina Juhani, Riku Turkki, Filip Miljković, Anton Martinsson, Lewis H Mervin, Kenneth R Pryde, Erik Müllers, Ian Barrett, Ola Engkvist, Andreas Bender, Kevin Moreau
Cell Morphological Profiling Enables High-Throughput Screening for PROteolysis TArgeting Chimera (PROTAC) Phenotypic Signature. ACS chemical biology 17 (7) (2022)
Lewis H Mervin, Maria-Anna Trapotsi, Avid M Afzal, Ian P Barrett, Andreas Bender, Ola Engkvist
Probabilistic Random Forest improves bioactivity predictions close to the classification threshold by taking into account experimental uncertainty. Journal of cheminformatics 13 (1) (2021)
Maria-Anna Trapotsi, Lewis H Mervin, Avid M Afzal, Noé Sturm, Ola Engkvist, Ian P Barrett, Andreas Bender
Comparison of Chemical Structure and Cell Morphology Information for Multitask Bioactivity Predictions. Journal of chemical information and modeling 61 (3) (2021)
Lewis H Mervin, Avid M Afzal, Ola Engkvist, Andreas Bender
Comparison of Scaling Methods to Obtain Calibrated Probabilities of Activity for Protein-Ligand Predictions. Journal of chemical information and modeling 60 (10) (2020)
Xian-Jun Fu, Lewis H Mervin, Xuebo Li, Huayun Yu, Jiaoyang Li, Siti Zuraidah Mohamad Zobir, Azedine Zoufir, Yang Zhou, Yongmei Song, Zhenguo Wang, Andreas Bender
Toward Understanding the Cold, Hot, and Neutral Nature of Chinese Medicines Using in Silico Mode-of-Action Analysis. Journal of chemical information and modeling 57 (3) (2017)

Lewis H Mervin.css-eqlu8i{font-size:small;padding-left:4px;} (Lewis Mervin)

Publication Activity (10 Years)

Top Topics

Top Venues

Lewis H Mervin (Lewis Mervin)